Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s stock price gapped up prior to trading on Thursday . The stock had previously closed at $15.61, but opened at $16.15. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $15.70, with a volume of 738 shares trading hands.
Several analysts recently weighed in on TLX shares. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a research note on Tuesday, November 19th. UBS Group initiated coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research report on Friday, November 15th. They issued a "buy" rating and a $21.00 price objective for the company.
Read Our Latest Research Report on Telix Pharmaceuticals Limited American Depositary Shares
The stock has a 50-day simple moving average of $15.61.
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.